Please enable JavaScript to continue using this application.

Compare $DNA vs $PSNL | Chartloom

Compare

$DNA vs $PSNL

Ginkgo Bioworks Holdings Inc · Personalis Inc

DNA

Ginkgo Bioworks Holdings Inc

PSNL

Personalis Inc

Compare $DNA vs $PSNL

Comparing Ginkgo Bioworks Holdings Inc and Personalis Inc

DNAGinkgo Bioworks Holdings Inc

PSNLPersonalis Inc

DNAGinkgo Bioworks Holdings Inc

Market cap

$810M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-51.5%

YTD performance

49.4%

52W performance

-19.2%

FCF yield

-21.6%

PSNLPersonalis Inc

Market cap

$1.71B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

17.58x

Rev growth (TTM)

-13.3%

YTD performance

103.8%

52W performance

84.3%

FCF yield

-5.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DNA

PSNL

Detailed metrics comparison

DNA

Ginkgo Bioworks Holdings Inc

PSNL

Personalis Inc

Market Cap

DNA$810M

PSNL$1.71B

Enterprise Value

DNA$726M

PSNL$1.61B

Price

DNA$13.00

PSNL$16.00

P/E Ratio

DNAN/A

PSNLN/A

P/S Ratio

DNA7.24x

PSNL24.52x

EV/Sales

DNA6.49x

PSNL23.18x

EV/EBITDA

DNA0.00x

PSNL0.00x

P/B Ratio

DNA1.98x

PSNL7.39x

P/FCF Ratio

DNAN/A

PSNLN/A

EV/FCF

DNA-4.15x

PSNL-15.99x

PEG Ratio

DNAN/A

PSNLN/A

Forward P/E (NTM)

DNAN/A

PSNLN/A

Forward P/S (NTM)

DNAN/A

PSNL17.58x

Revenue (TTM)

DNA$112M

PSNL$70M

Revenue Growth (YoY)

DNA-51.5%

PSNL-13.3%

Forward Rev Growth

DNA13.4%

PSNL37.3%

Gross Margin (TTM)

DNA77.7%

PSNL12.7%

Operating Margin (TTM)

DNA0.0%

PSNL0.0%

EBITDA Margin (TTM)

DNA-210.7%

PSNL-150.1%

Net Margin (TTM)

DNA-260.0%

PSNL-153.8%

FCF Margin (TTM)

DNA-156.3%

PSNL-144.9%

Net Income (TTM)

DNA$-291M

PSNL$-107M

FCF (TTM)

DNA$-175M

PSNL$-101M

EPS (TTM)

DNA-$4.68

PSNL-$1.02

ROE (TTM)

DNA-6021.0%

PSNL-4647.0%

ROA (TTM)

DNA-2685.0%

PSNL-3530.0%

ROIC (TTM)

DNA-6021.0%

PSNL-4601.0%

Cash

DNA$85M

PSNL$94M

Debt

DNA$0

PSNL$898K

Net Cash/Debt

DNA$85M

PSNL$93M

Current Ratio (TTM)

DNA4.57x

PSNL5.28x

Quick Ratio (TTM)

DNA4.37x

PSNL4.91x

Debt/Equity (TTM)

DNA0.00x

PSNL0.00x

Debt/Assets (TTM)

DNA0.0%

PSNL0.0%

Interest Coverage (TTM)

DNAN/A

PSNLN/A

Net Debt/EBITDA (TTM)

DNA0.00x

PSNL0.00x

Beta

DNA1.69

PSNL2.37

52W Performance

DNA-19.2%

PSNL84.3%

YTD Performance

DNA49.4%

PSNL103.8%

% from 52W High

DNA-28.6%

PSNL-15.3%

% from 52W Low

DNA142.1%

PSNL222.9%

Asset Turnover (TTM)

DNA0.10x

PSNL0.23x

FCF Yield (TTM)

DNA-21.6%

PSNL-5.9%

Earnings Yield (TTM)

DNA-35.9%

PSNL-6.3%

Dividend Yield (TTM)

DNAN/A

PSNLN/A

Rule of 40

DNA-207.8

PSNL-158.2

EV/GP/RG

DNA0.42

PSNL4.29

Ticker research

View DNA research View PSNL research

Metric	DNA Ginkgo Bioworks Holdings Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$810M	$1.71B
Enterprise Value	$726M	$1.61B
Price	$13.00	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	7.24x	24.52x
EV/Sales	6.49x	23.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.98x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.15x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	17.58x
Revenue & Growth
Revenue (TTM)	$112M	$70M
Revenue Growth (YoY)	-51.5%	-13.3%
Forward Rev Growth	13.4%	37.3%
Profitability
Gross Margin (TTM)	77.7%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-210.7%	-150.1%
Net Margin (TTM)	-260.0%	-153.8%
FCF Margin (TTM)	-156.3%	-144.9%
Net Income (TTM)	$-291M	$-107M
FCF (TTM)	$-175M	$-101M
EPS (TTM)	-$4.68	-$1.02
ROE (TTM)	-6021.0%	-4647.0%
ROA (TTM)	-2685.0%	-3530.0%
ROIC (TTM)	-6021.0%	-4601.0%
Financial Health
Cash	$85M	$94M
Debt	$0	$898K
Net Cash/Debt	$85M	$93M
Current Ratio (TTM)	4.57x	5.28x
Quick Ratio (TTM)	4.37x	4.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	2.37
52W Performance	-19.2%	84.3%
YTD Performance	49.4%	103.8%
% from 52W High	-28.6%	-15.3%
% from 52W Low	142.1%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.23x
FCF Yield (TTM)	-21.6%	-5.9%
Earnings Yield (TTM)	-35.9%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-207.8	-158.2
EV/GP/RG	0.42	4.29
Ticker research	View DNA research	View PSNL research

Valuation

P/S Ratio

DNA

7.24x

PSNL

24.52x

EV/FCF

PSNL

-15.99x

DNA

-4.15x

Growth & revenue

Revenue Growth TTM

PSNL

-13.3%

DNA

-51.5%

Forward Revenue Growth

PSNL

37.3%

DNA

13.4%

Profitability & performance

Gross Margin

DNA

77.7%

PSNL

12.7%

ROE

PSNL

-4647.0%

DNA

-6021.0%

FCF Yield %

PSNL

-5.9%

DNA

-21.6%

52-Week Performance

PSNL

84.3%

DNA

-19.2%

Detailed metrics comparison

DNA

Ginkgo Bioworks Holdings Inc

PSNL

Personalis Inc

Market Cap

DNA$810M

PSNL$1.71B

Enterprise Value

DNA$726M

PSNL$1.61B

Price

DNA$13.00

PSNL$16.00

P/E Ratio

DNAN/A

PSNLN/A

P/S Ratio

DNA7.24x

PSNL24.52x

EV/Sales

DNA6.49x

PSNL23.18x

EV/EBITDA

DNA0.00x

PSNL0.00x

P/B Ratio

DNA1.98x

PSNL7.39x

P/FCF Ratio

DNAN/A

PSNLN/A

EV/FCF

DNA-4.15x

PSNL-15.99x

PEG Ratio

DNAN/A

PSNLN/A

Forward P/E (NTM)

DNAN/A

PSNLN/A

Forward P/S (NTM)

DNAN/A

PSNL17.58x

Revenue (TTM)

DNA$112M

PSNL$70M

Revenue Growth (YoY)

DNA-51.5%

PSNL-13.3%

Forward Rev Growth

DNA13.4%

PSNL37.3%

Gross Margin (TTM)

DNA77.7%

PSNL12.7%

Operating Margin (TTM)

DNA0.0%

PSNL0.0%

EBITDA Margin (TTM)

DNA-210.7%

PSNL-150.1%

Net Margin (TTM)

DNA-260.0%

PSNL-153.8%

FCF Margin (TTM)

DNA-156.3%

PSNL-144.9%

Net Income (TTM)

DNA$-291M

PSNL$-107M

FCF (TTM)

DNA$-175M

PSNL$-101M

EPS (TTM)

DNA-$4.68

PSNL-$1.02

ROE (TTM)

DNA-6021.0%

PSNL-4647.0%

ROA (TTM)

DNA-2685.0%

PSNL-3530.0%

ROIC (TTM)

DNA-6021.0%

PSNL-4601.0%

Cash

DNA$85M

PSNL$94M

Debt

DNA$0

PSNL$898K

Net Cash/Debt

DNA$85M

PSNL$93M

Current Ratio (TTM)

DNA4.57x

PSNL5.28x

Quick Ratio (TTM)

DNA4.37x

PSNL4.91x

Debt/Equity (TTM)

DNA0.00x

PSNL0.00x

Debt/Assets (TTM)

DNA0.0%

PSNL0.0%

Interest Coverage (TTM)

DNAN/A

PSNLN/A

Net Debt/EBITDA (TTM)

DNA0.00x

PSNL0.00x

Beta

DNA1.69

PSNL2.37

52W Performance

DNA-19.2%

PSNL84.3%

YTD Performance

DNA49.4%

PSNL103.8%

% from 52W High

DNA-28.6%

PSNL-15.3%

% from 52W Low

DNA142.1%

PSNL222.9%

Asset Turnover (TTM)

DNA0.10x

PSNL0.23x

FCF Yield (TTM)

DNA-21.6%

PSNL-5.9%

Earnings Yield (TTM)

DNA-35.9%

PSNL-6.3%

Dividend Yield (TTM)

DNAN/A

PSNLN/A

Rule of 40

DNA-207.8

PSNL-158.2

EV/GP/RG

DNA0.42

PSNL4.29

Ticker research

View DNA research View PSNL research

Metric	DNA Ginkgo Bioworks Holdings Inc	PSNL Personalis Inc
Market & Valuation
Market Cap	$810M	$1.71B
Enterprise Value	$726M	$1.61B
Price	$13.00	$16.00
P/E Ratio	N/A	N/A
P/S Ratio	7.24x	24.52x
EV/Sales	6.49x	23.18x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.98x	7.39x
P/FCF Ratio	N/A	N/A
EV/FCF	-4.15x	-15.99x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	17.58x
Revenue & Growth
Revenue (TTM)	$112M	$70M
Revenue Growth (YoY)	-51.5%	-13.3%
Forward Rev Growth	13.4%	37.3%
Profitability
Gross Margin (TTM)	77.7%	12.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-210.7%	-150.1%
Net Margin (TTM)	-260.0%	-153.8%
FCF Margin (TTM)	-156.3%	-144.9%
Net Income (TTM)	$-291M	$-107M
FCF (TTM)	$-175M	$-101M
EPS (TTM)	-$4.68	-$1.02
ROE (TTM)	-6021.0%	-4647.0%
ROA (TTM)	-2685.0%	-3530.0%
ROIC (TTM)	-6021.0%	-4601.0%
Financial Health
Cash	$85M	$94M
Debt	$0	$898K
Net Cash/Debt	$85M	$93M
Current Ratio (TTM)	4.57x	5.28x
Quick Ratio (TTM)	4.37x	4.91x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.69	2.37
52W Performance	-19.2%	84.3%
YTD Performance	49.4%	103.8%
% from 52W High	-28.6%	-15.3%
% from 52W Low	142.1%	222.9%
Efficiency & Yields
Asset Turnover (TTM)	0.10x	0.23x
FCF Yield (TTM)	-21.6%	-5.9%
Earnings Yield (TTM)	-35.9%	-6.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-207.8	-158.2
EV/GP/RG	0.42	4.29
Ticker research	View DNA research	View PSNL research